A review of SAMR's 2024 conditional clearance decisions shows a consistent pattern: structural remedies with hold-separate commitments, behavioral remedies with sunset clauses, and a strong preference for early engagement.
Three takeaways for deal lawyers.
First, the SAMR review clock is not the problem. The problem is arriving at SAMR without a remedy plan. Filers that arrive with a credible divestiture buyer already identified clear faster than filers that arrive with a theory.
Second, the hold-separate period is now longer. Plan for it in the integration timeline, not as an afterthought.
Third, behavioral remedies are not dead. They are, however, more carefully drafted. The 2024 decisions show SAMR accepting behavioral commitments when they are paired with verifiable metrics and short sunset periods.
The practical implication: a Chinese merger filing is no longer a procedural step. It is a substantive negotiation that should be staffed accordingly.
Written by Anya Petrova, Partner.
This article is for general information only and is not legal advice.